Search results
Found 596 matches for
People with Rheumatoid Arthritis (RA) could soon benefit from a new drug treatment that not only suppresses inflammation but also significantly reduces patient reported pain scores. Otilimab is a monoclonal antibody, biologic drug, which targets and suppresses the inflammatory cytokine GM-CSF.
Ensuring an inclusive and healthy working environment, empowering individuals and building collegiality
Tuesday, 26 November 2024, 12pm to 1pm
How research is managed and undertaken, How research ensures value
Tuesday, 04 March 2025, 12pm to 1pm
Meet Chris
-
Christopher Buckley
Kennedy Professor of Translational Rheumatology and Director of Clinical Research
